Studies in individuals with autoimmune diseases suggest that the PD-1/PD-L1 signaling pathway may exert an important regulatory function in Type I diabetes, LES, Sjögren's syndrome and also in RA (47), underlining the important role of PD-1 for maintaining self-tolerance. The gene discussed is PDCD1; the disease is Sjogren syndrome.